N Rizzuto
Overview
Explore the profile of N Rizzuto including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
204
Citations
1274
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Boaretto F, Vettori A, Casarin A, Vazza G, Muglia M, Rossetto M, et al.
Neurology
. 2010 Jun;
74(23):1919-21.
PMID: 20530328
No abstract available.
2.
Padua L, Pareyson D, Aprile I, Cavallaro T, Quattrone D, Rizzuto N, et al.
Neurol Sci
. 2009 Dec;
31(2):175-8.
PMID: 20016922
Charcot-Marie-Tooth (CMT) disease is the most frequent inherited neuropathy, no therapies are available at the moment but clinical trials are ongoing. For that reason it is very important to know...
3.
Fabrizi G, Taioli F, Cavallaro T, Ferrari S, Bertolasi L, Casarotto M, et al.
Neurology
. 2009 Apr;
72(13):1160-4.
PMID: 19332693
Background: Autosomal recessive demyelinating Charcot-Marie-Tooth neuropathy type 4H (CMT4H) manifests early onset, severe functional impairment, deforming scoliosis, and myelin outfoldings in the nerve biopsy. Mutations in the FGD4 gene encoding...
4.
Mazzucco S, Anzola G, Ferrarini M, Taioli F, Olivato S, Burlina A, et al.
Eur Neurol
. 2008 Oct;
61(1):46-9.
PMID: 18948701
Background/aims: Up to more than 50% of cryptogenetic stroke patients and patients with migraine with aura (MA) are found to have a right-to-left shunt (RLS), which is usually due to...
5.
Mazzucco S, Bifari F, Trombetta M, Guidi G, Mazzi M, Anzola G, et al.
Nutr Metab Cardiovasc Dis
. 2008 Sep;
19(3):205-10.
PMID: 18804986
Background And Aims: Flow mediated dilation (FMD) of peripheral conduit arteries is a well-established tool to evaluate endothelial function. The aims of this study are to apply the FMD model...
6.
Padua L, Aprile I, Cavallaro T, Commodari I, Pareyson D, Quattrone A, et al.
Neurol Sci
. 2008 Jul;
29(3):157-62.
PMID: 18612763
Objective: To assess which are the clinical examination tests that are more related to quality of life (QoL), depression, and disability in CMT patients. Design: Large prospective multicenter study through...
7.
Padua L, Pareyson D, Aprile I, Cavallaro T, Quattrone A, Rizzuto N, et al.
Neuromuscul Disord
. 2008 Feb;
18(3):199-203.
PMID: 18242090
The Italian CMT study group performed a multicentre, multidimensional, longitudinal 2-year follow-up study using validated measurements of neurological impairment, disability and quality of life. The aim of the study was...
8.
Fabrizi G, Ferrarini M, Cavallaro T, Cabrini I, Cerini R, Bertolasi L, et al.
Neurology
. 2007 Jul;
69(3):291-5.
PMID: 17636067
Background: Recently, mutations affecting different domains of dynamin-2 (DNM2) were associated alternatively with autosomal dominant centronuclear myopathy or dominant intermediate (demyelinating and axonal) Charcot-Marie-Tooth disease (CMT) type B. Objective: To...
9.
Filosto M, Tonin P, Vattemi G, Bertolasi L, Simonati A, Rizzuto N, et al.
Neurology
. 2007 Jan;
68(3):181-6.
PMID: 17224570
Objective: To evaluate the muscle biopsy findings from 240 patients who had isolated muscle pain. Methods: Histopathology, immunohistochemistry for dystrophin, dystrophin-related proteins, major histocompatibility complex type I, and biochemical analysis...
10.
Padua L, Pazzaglia C, Cavallaro T, Commodari I, Pareyson D, Quattrone A, et al.
Eur J Neurol
. 2007 Jan;
14(1):e45-6.
PMID: 17222096
No abstract available.